Daniel L. Alkon - 04 Jun 2021 Form 3 Insider Report for Synaptogenix, Inc. (SNPX)

Role: Chief Scientific Officer, Director
Signature: /s/ Daniel L. Alkon
Issuer symbol: SNPX
Transactions as of: 04 Jun 2021
Net transactions value: $0
Form type: 3
Filing time: 14 Jun 2021, 20:15:20 UTC
Next filing: 16 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SNPX	Common Stock, par value $0.0001 per share						1,484	04 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	SNPX	Stock Option (Right to Buy)							04 Jun 2021	Common Stock, par value $0.0001 per share	31,250	$9.84	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The holder's options become exercisable as follows: (i) 50% of the options shall become exercisable immediately on January 13, 2021 and (ii) 50% of the options shall become exercisable upon the holder's completion of one year of service following January 13, 2021.